Gadobutrol Injection/API

• 

Founded in 1992, BeijingBeiluPharmaceuticalsCompanyLimited is mainly engaged in the research & development, production and sales of pharmaceutical products. It is high-tech innovation company with core competence in the Contrast Media domestic. It has around 650 employees with 0.82 Bn/￥ revenue in 2019. Beiluprovides complete Contrast Media products Include ct contrast medium, mri contrast medium, gadopentetate dimeglumine,etc, and it is the leading manufacturer in the Contrast Media field in China. It is one of the 1st batches of listed enterprises in GEM of SZSE (Ticker: 300016.SZ) in China.

In 2020, Beilu launched its macrocyclic Contrast Media- Gadobutrol Injection, it is gadolinium-based non-ionic Contrast Media, a paramagnetic Contrast Media used in various parts of the body lesion (including the brain and spinal cord) MRI imaging and angiography examination. Its macrocyclic nature ensures it is well-tolerated with a good safety profile for MRI Contrast. As a professional contrast media manufacturer, Beilu can provide you with the high concentration gadobutrol gadovistthat leads to a better image with lower volume.

Product name: Gadobutrol Injection
Generic name: Gadobutrol Injection
Type: Injectable Contrast Media for MRI, Macrocyclic Contrast Media
Ingredients: Gadobutrol
Specification: Gadovist 7.5 ml - 4.5354 g, injection gadobutrol 0.1 ml
Administration: Intravenous administration only.
Adverse reactions: See the details from the package insert.

Shelf life: 24 months
Indication of Gadopentetate Dimegumine Injection
Magnetic resonance imaging of the central nervous system (brain and spinal cord), abdomen, chest, pelvis, limbs and other human organs and tissues.

Precautions of Gadopentetate Dimegumine Injection
1. Use with caution in patients with severe kidney damage, epilepsy, hypotension, asthma and other allergic respiratory diseases and those with allergic tendencies.
2. Pay attention to avoid the extravasation of the liquid during the gadobutrol injection uses so as to prevent tissue pain.
3. The serum iron and bilirubin levels of some patients will increase slightly after medication, but they are asymptomatic and can return to normal within 24 hours.
4. Pregnant women and breastfeeding women should use it with caution. Animal experiments show that a small amount of medicine liquid enters the milk.
5. The effective enhancement time of this product is 45 minutes. MRI examination should be performed immediately after intravenous injection.
6. The remaining medicine liquid after one examination should not be used again.
7. When applying the gadovist doses, follow the relevant safety regulations in magnetic resonance imaging.
8. GBCAs should be used with caution. When plain scan MRI cannot obtain the corresponding vital diagnostic information, GBCAs can be used, and the lowest approved dose is used as much as possible.
9. Gadolinium deposition

Current evidence shows that after repeated use of macrocyclic gbca, trace amounts of gadolinium can remain in the brain and other body tissues. Research reports have shown that multiple uses of GBCAs can increase the intensity of brain signals, especially in the dentate nucleus and globus pallidus. Currently, there are more reports about linear GBCAs and fewer reports about macrocyclic GBCAs. Animal experiments have shown that the amount of gadolinium deposited after repeated use of linear GBCAs is higher than that of repeated use of macrocyclic gadolinium.

The clinical significance of brain gadolinium deposition is unclear.

In order to minimize the potential risks associated with gadolinium deposition in the brain, it must be used in strict accordance with the indications and approved doses. It is recommended to use the lowest approved dose that meets the requirement of diagnosis and perform a careful benefit-risk assessment and patient informed communication before repeated administration.

If you have interest, we will offer gadobutrol injection uses and gadovist price lists to you.

Other supplier products

	Contrast Media Manufacturing Company	For the purpose of medical imaging, a certain substance is introduced into the human body to change the image contrast of local tissues of the body...
	Gadopentetate Dimeglumine Injection/API	Since Gadopentetate Dimeglumine Injection was launched in 1992 by Beilu Pharma in China, it was highly recommended and accepted by the radiologist,...
	Contrast Media	For the purpose of medical imaging, a certain substance is introduced into the human body to change the image contrast of local tissues of the body...
	CT/X-Ray Contrast Media	The main component of CT/X-ray Contrast Media is iodine. The Iodinated Contrast Media is a colorless, transparent, slightly viscous liquid. At pres...
	Gadobutrol Injection/API	In 2020, Beilulaunched its macrocyclic Contrast Media- Gadobutrol Injection, it is gadolinium-based non-ionic Contrast Media, a paramagnetic Contra...

Same products

	Sulfachloropyrazine Sodium Soluble Powder 30% 500g	Seller: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd.	Trade Name: Shengxue QiulingCommon Name: Sulfachloropyrazine Sodium Soluble PowderMain Ingredient...
	Carbasalate Calcium Soluble Powder Wholesale Price	Seller: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd.	Brand Name: Shengxue ResunGeneric Name: Carbasalate Calcium Soluble PowderActive Ingredient: Carb...
	High-quality Tylvalosin Tartrate Premix	Seller: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd.	Brand name:Shengxue TaikesCommon name:Tylvalosin tartrate premixMain ingredient:Tylvalosin tartra...
	Ferric Ammonium Citrate Effervescent Granules	Seller: Beijing Beilu Pharmaceutical Co., Ltd	Ferric Ammonium Citrate Effervescent Granules was launched in 2004. It is an oral magnetic resona...
	Diethylenetriaminepentaacetic acid (DTPA)	Seller: Beijing Beilu Pharmaceutical Co., Ltd	Diethylenetriaminepentaaceticacid (DTPA) CAS No.: 67-43-6 Molecular formula: C₁₄H₂₃N₃O₁₀ M...